PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 33 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $330,065 | +20.2% | 198,835 | +44.8% | 0.00% | – |
| Q2 2023 | $274,594 | +59.1% | 137,297 | +67.1% | 0.00% | – |
| Q1 2023 | $172,570 | +1432.9% | 82,176 | +900.1% | 0.00% | – |
| Q4 2022 | $11,258 | +25.1% | 8,217 | 0.0% | 0.00% | – |
| Q3 2022 | $9,000 | 0.0% | 8,217 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | -64.0% | 8,217 | -65.6% | 0.00% | – |
| Q1 2022 | $25,000 | -97.7% | 23,917 | -98.2% | 0.00% | – |
| Q4 2021 | $1,075,000 | -64.6% | 1,292,963 | -43.4% | 0.00% | – |
| Q3 2021 | $3,039,000 | -14.5% | 2,285,075 | +22.7% | 0.00% | – |
| Q2 2021 | $3,556,000 | – | 1,861,819 | +3723538.0% | 0.00% | – |
| Q1 2021 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 50 | +400.0% | 0.00% | – |
| Q1 2020 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 2,470,332 | $8,967,000 | 6.83% |
| Psagot Value Holdings Ltd. | 470,255 | $1,707,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 212,591 | $772,000 | 0.02% |
| UBS OCONNOR LLC | 150,000 | $544,000,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 10,042 | $36,000 | 0.01% |
| Renaissance Technologies | 488,634 | $1,774,000 | 0.00% |
| Squarepoint Ops LLC | 22,068 | $80,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 222 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 50,280 | $183,000 | 0.00% |